4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-031803
Options or other derivatives
- Chief Business Officer acquired 225,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Sniecinski Megan Chief Business Officer | 2020-12-15 | Grant or award · Emp. Stock Option (Right to Buy) | +225,000 | 225,000 | D | ||
Loading xslF345X03/form4.xml…